BioSpace News Archive

Apollo Endosurgery, Inc. announced today the electronic publication of the landmark Multi-center ESG Randomized Interventional Trial (MERIT) Study in The Lancet .

Ocugen, Inc. today announced that it will host a conference call and simultaneuous webcast to discuss the Company’s second quarter 2022 financial results and provide a business update at 8:30 a.m. ET on Friday, August 5, 2022.

ProSomnus, a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced it will host a first of its kind symposium focused on the shift toward emerging therapies for people diagnosed with OSA.

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2022.

Novasenta Inc. , a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, today announced the completion of $40 million in Series A financing led by UPMC Enterprises , the innovation, venture capital and commercialization arm of leading health system UPMC.

Moderna, Inc. today announced that the U.S. government has secured 66 million doses of a Moderna COVID-19 vaccine booster candidate, mRNA-1273.222, a bivalent booster candidate containing Spikevax™ plus the Omicron BA.4/5 strain mRNA.

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA), an advanced biotherapeutic research and technology company, today announced financial results for the full fiscal year 2022 ended April 30, 2022.

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, started and will be completing this weekend, a Community Fundraising effort to drive drug development.

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announced today the pricing of its underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $2.00 per share.

TriNetX, today announced the inaugural members of the Pediatric Collaboratory Network (PCN), comprised of Children’s National Hospital, WVU Medicine Children’s (Morgantown, WV), Children’s HealthSM (Dallas, TX), and Johns Hopkins All Children’s Hospital (St. Petersburg, FL).